New Key Statistics Module, Z-Score and F-Score
NAS:VIR Key Ratios
| Market Cap $ M | 1,394.60 |
| Enterprise Value $ M | 365.92 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.90 |
| Price/Sales | 31.64 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 43.00 |
| EPS (TTM) $ | -4.01 |
| Beneish M-Score | -2.31 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.59 |
| EV-to-EBITDA | -0.61 |
| PEG | -- |
| Shares Outstanding M | 136.06 |
| Net Margin (%) | -1,226.38 |
| Operating Margin % | -1,411.85 |
| Pre-tax Margin (%) | -1,250.41 |
| Quick Ratio | 12.90 |
| Current Ratio | 12.90 |
| ROA % (ttm) | -25.28 |
| ROE % (ttm) | -31.39 |
| ROIC % (ttm) | -153.87 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.92 |
VIR Number of Guru Trades
VIR Volume of Guru Trades
Gurus Latest Trades with NAS:VIR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VIR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Vir Biotechnology Inc Insider Transactions
No Available Data
News about NAS:VIR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers